Profile Picture

Surbhit Mukesh Shah - Profile

Surbhit Mukesh Shah, Additional Director and Director, with 12 companies.

About Surbhit Mukesh Shah

Surbhit Mukesh Shah has 18 years in corporate governance. Holds Additional Director and Director roles. Currently with 9 companies, including Radiant Parenterals Limited and Rekvina Pharmaceuticals (India) Private Limited. Formerly with 3 companies, such as Phc Buildcon Private Limited and Shakun Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 9
Past Companies 3
Total Affiliations 12
Oldest Company Age 37
Companies Associated with Surbhit Mukesh Shah
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Surbhit Mukesh Shah?

Surbhit Mukesh Shah has 18 years in corporate governance. Holds Additional Director and Director roles. Currently with 9 companies, including Radiant Parenterals Limited and Rekvina Pharmaceuticals (India) Private Limited. Formerly with 3 companies, such as Phc Buildcon Private Limited and Shakun Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Surbhit Mukesh Shah's role in current companies?

Surbhit Mukesh Shah is associated with 9 companies as Additional Director and Director.

What industries does Surbhit Mukesh Shah specialize in?

Surbhit Mukesh Shah has expertise in General Business.

How many years of experience does Surbhit Mukesh Shah have?

Surbhit Mukesh Shah has 18 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available